发明名称 |
AAV vectors for in vivo gene therapy of rheumatoid arthritis |
摘要 |
Disclosed is a method for delivering a nucleic acid molecule to a rheumatoid synovial cells in vivo, the method comprising the steps of (a) providing a recombinant AAV virion (rAAV) comprising capsid proteins of AAV serotype 5 or AAV serotype 2, wherein the rAAV virion comprises a rAAVX vector, the rAAVX vector comprising an expression element operably linked to a nucleic acid sequence; and, (b) bringing the rAAV virion into contact with the synovial cell, whereby transduction of the rAAVX vector results in expression of the nucleic acid sequence in the transduced synovial cells.
|
申请公布号 |
NZ545656(A) |
申请公布日期 |
2009.02.28 |
申请号 |
NZ20040545656 |
申请日期 |
2004.09.01 |
申请人 |
ACADEMISCH MEDISCH CENTRUM;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) |
发明人 |
TAK, PAUL PETER;JORGENSEN, CHRISTIAN |
分类号 |
(IPC1-7):C12N15/861;A61K48/00;A61P19/02 |
主分类号 |
(IPC1-7):C12N15/861 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|